• Kwangdong Pharmaceutical's reported combined stake in Kwangdong Healthbio rose to 79.57% from 65.61%, totaling 10,096,012 shares.
• Affiliate Kwangdong Life & Health contracted to buy 1,770,958 voting shares on Nov. 5, 2026, for KRW 2.55 billion.
• The purchase price was KRW 1,442 per share; closing is scheduled for Jan. 4, 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kwangdong Healthbio Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261110000422), on November 10, 2026, and is solely responsible for the information contained therein.